NCT02204683 Pharmacokinetic Study of Intravitreal Aflibercept Injection in Eyes With Wet Age-related Macular Degeneration Status COMPLETED Phase PHASE1
NCT02174211 A Pharmacokinetic Study: Ranibizumab, Aflibercept and the Effect of Vitrectomy. Status COMPLETED Phase NA
NCT02157077 Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration Status COMPLETED Phase PHASE3
NCT02129257 Clinical Trial of Combination Chemotherapy With Aflibercept in Patients With Advanced Colorectal Cancer Status COMPLETED Phase PHASE2
NCT02118831 Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGF Status COMPLETED Phase PHASE1/PHASE2
NCT02072408 Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal Vasculopathy Status COMPLETED Phase PHASE4
NCT02002377 Intravitreal Aflibercept in Wet Age Related Macular Degeneration Patients With an Incomplete Response to Routine Ranibizumab Injections Status TERMINATED Phase PHASE4
NCT01988246 Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery Status COMPLETED Phase PHASE1/PHASE2
NCT01969708 Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Status COMPLETED Phase PHASE3
NCT01965041 Intravitreal Aflibercept Injections In The Treatment Of Pattern Dystrophy Status WITHDRAWN Phase NA
NCT01961414 Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910 Status UNKNOWN Phase PHASE4
NCT01958918 Efficacy of Ranibizumab Prn Treatment Compared to Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability in Patients With Wet AMD Status COMPLETED Phase PHASE4
NCT01950741 Effect of Intravitreal VEGF-Trap Eye on Polypoidal Choroidal Vasculopathy Status COMPLETED Phase PHASE4
NCT01882868 A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan Status COMPLETED Phase PHASE2
NCT01857544 Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy Status UNKNOWN Phase PHASE4
NCT01843725 Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast Cancers Status COMPLETED Phase PHASE1
NCT01824225 Study of PRN and Every 2months Intravitreal Aflibercept for Age Related Macular Degeneration Status COMPLETED Phase PHASE4
NCT01802684 OPTIMOX-aflibercept as First-line Therapy in Patients With Unresectable Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2